<DOC>
	<DOCNO>NCT01120119</DOCNO>
	<brief_summary>Reduction vitamin D level report subject recent onset type 1 diabetes . Several study suggest vitamin D supplementation early childhood decrease risk develop type 1 diabetes , therefore vitamin D deficiency might play role disease pathogenesis . We investigate whether supplementation active form vitamin D ( calcitriol ) subject recent-onset type 1 diabetes protect residual beta cell function evaluate C peptide improve glycaemic control evaluate HbA1c insulin requirement . Thirty-four subject ( age range 11-35 year , median 18 year ) recent-onset type 1 diabetes ( &lt; 12 week duration ) high basal C-peptide &gt; 0.25 nmol/l randomize double-blind trial calcitriol ( active form vitamin D , 1.25-dihydroxyvitamin D3 [ 1,25- ( OH ) 2D3 ] ) dose 0.25 ug/day placebo , follow 2 year .</brief_summary>
	<brief_title>Efficacy Calcitriol Recent Onset Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>1. diagnosis type 1 diabetes accord American Diabetes Association ( ADA ) guideline ; 2. age presentation 11 35 year ; 3. duration clinical disease ( since begin insulin therapy ) &lt; 12 week ; 4. baseline Cpeptide &gt; 0.25 nmol/l ; 5. medical contraindication major chronic disease ; 6. willingness capability participate regular followup . 1. cardiovascular disease ; 2. renal disease ; 3. liver disease ; 4. neurological disorder ; 5. allergic diathesis ; 6. hyperparathyroidism ; 7. neoplasia .</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2005</verification_date>
</DOC>